Skip to content

Clinical trials

Completed Phase 2/3 trials in Peru

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2/3 Status: Completed Country / region: Peru Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20091
20102
20141
20151
20161
20205
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca1
Complejo Hospitalario Dr. Arnulfo Arias Madrid1
CureVac1
Daiichi Sankyo1
InflaRx GmbH1
Insmed Incorporated1
Kiniksa Pharmaceuticals International, plc1
MedImmune LLC1
Merck Sharp & Dohme LLC1
National Institute of Allergy and Infectious Diseases (NIAID)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-194
Diabetes Mellitus, Type 22
Coronavirus Infections1
Demyelinating Diseases1
Dermatomyositis1
Epilepsy1
HIV Infections1
Hemangioma, Capillary1
Hypertension1
Laron Syndrome1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.